As a leading protein and antibody solutions provider, GenWay has a proprietary technology platform and an international network to provide our clients with antibodies, recombinant proteins, full-length cDNAs, gene expression vectors, cell lines and tissue samples. We are the recognized world leader in gene-specific IgY (chicken) antibodies.

GenWay offers both custom and catalog products. We recently licensed to Beckman Coulter a novel product line of IgY-based immunoaffinity protein separation (Seppro-TM) for highly specific removal of abundant plasma, serum or cellular proteins, which is a critical step in proteomic profiling and biomarker/drug target discovery. By applying tissue microarray technology, GenWay also enables target validation and screening of important disease-related proteins.

Potential partners and clients may also be interested GenWay services including IHC/ICC validation of protein targets; and proteomic research services, including sample preparation,2D-gel analysis, and LC or HPLC-coupled Mass Spectrometry for protein identification and profiling.
OEM Service:
No. of R&D Staff:
Estimated Annual Sales (USD): US$1 Million - US$2.5 Million
Export Percentage:
Quality Control:
Legal Representative/CEO:
Factory Size (Sq.meters):
Factory Location:
Corporate Status:

Business Type: Year Established: 1998 Number of Employees: Legal Representative / CEO: Wei-Wei Zhang Website: http://www.genwaybio.com Certificates: Brands: Trade & Market Main Markets: Main Customers: Export Percentage: Trade Shows: Factory Information Factory Size (Sq.meters): Factory Location: QA/QC: Number of Production Lines: Number of R&D Staff: Contract Manufacturing: